ConductScience.org, home

Library / Genes

TNFRSF17: TNF receptor superfamily member 17

1 protein, 512 patents, 5 drugs, 190 trials, 1,903 NIH grants and 5,303 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolTNFRSF17HGNC
NameTNF receptor superfamily member 17HGNC
NCBI Gene ID608NCBI Gene
HGNC IDHGNC:11913HGNC
EnsemblENSG00000048462NCBI Gene
AliasesBCM, BCMA, CD269, TNFRSF13ANCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q02223Tumor necrosis factor receptor superfamily member 1718411Ensembl, GeneID, HGNCUniProt

Patents 512

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
WO 2026220001 A12026-10-2229Q02223Espacenet
EP 4825397 A12026-10-2129Q02223Espacenet
WO 2026171694 A12026-08-203Q02223Espacenet
JP 2026113544 A2026-07-07165Q02223Espacenet
JP 2026097979 A2026-06-1611Q02223Espacenet
JP 2026098036 A2026-06-16165Q02223Espacenet
JP 2026516673 A2026-05-261Q02223Espacenet
JP 2026516087 A2026-05-1921Q02223Espacenet
JP 2026515434 A2026-05-1874Q02223Espacenet
JP 2026514753 A2026-05-131Q02223Espacenet

Drugs 5

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
BELANTAMAB MAFODOTINCHEMBL4298209Tumor necrosis factor receptor superfamily member 17 binding agentBINDING AGENTChEMBL
CILTACABTAGENE AUTOLEUCELCHEMBL4802263Tumor necrosis factor receptor superfamily member 17 binding agentBINDING AGENTChEMBL
ELRANATAMABCHEMBL4297809Tumor necrosis factor receptor superfamily member 17 binding agentBINDING AGENTChEMBL
IDECABTAGENE VICLEUCELCHEMBL4298199Tumor necrosis factor receptor superfamily member 17 binding agentBINDING AGENTChEMBL
TECLISTAMABCHEMBL4594505Tumor necrosis factor receptor superfamily member 17 binding agentBINDING AGENTChEMBL

Trials 190

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07605416TECLISTAMABPHASE2ClinicalTrials.gov
NCT07581704TECLISTAMABPHASE1ClinicalTrials.gov
NCT07518186TECLISTAMABPHASE3ClinicalTrials.gov
NCT07463807TECLISTAMABPHASE1/PHASE2ClinicalTrials.gov
NCT07454382ELRANATAMABPHASE2ClinicalTrials.gov
NCT07391761ELRANATAMABClinicalTrials.gov
NCT07382739ELRANATAMABPHASE2ClinicalTrials.gov
NCT07320326ELRANATAMABClinicalTrials.gov
NCT07285239BELANTAMAB MAFODOTINPHASE3ClinicalTrials.gov
NCT07280013ELRANATAMABPHASE1ClinicalTrials.gov

NIH grants 1903

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant902,025NIH's project files
P30CA016672Cancer Center Support Grant312,025NIH's project files
P01CA155258Integrative Oncogenomics of Multiple Myeloma202,025NIH's project files
P50CA186781Mayo Clinic Multiple Myeloma SPORE202,025NIH's project files
P01CA214278Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19162,025NIH's project files
P01CA018029Adult Leukemia Research Center102,025NIH's project files
P30CA016520Abramson Cancer Center Support Grant92,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant92,025NIH's project files
P30CA086862Cancer Center Support Grant92,025NIH's project files
T32AI055428Immune System Development and Regulation82,025NIH's project files

Papers 5303

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42819898PubTator, text miningPubMed
42819529PubTator, text miningPubMed
42815880PubTator, text miningPubMed
42814419PubTator, text miningPubMed
42812406PubTator, text miningPubMed
42811422PubTator, text miningPubMed
42809700PubTator, text miningPubMed
42809698PubTator, text miningPubMed
42809697PubTator, text miningPubMed
42809695PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license